Migraine Two-Hour Pain Response Efficacy Standard Suggested By Committee

A two-hour pain-free response endpoint should be the primary measure of efficacy for migraine drugs, members of FDA's Peripheral & Central Nervous System Drugs Advisory Committee suggested Aug. 4